Never conclude with a negative result, explore all possibilities before changing your hypothesis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Dr. Catherine Figarella is a world expert in the isolation and characterization of human exocrine pancreatic proteins (enzymatic and non-enzymatic ones). She was a pioneer in the identification and characterization of the numerous zymogens present in pancreatic juice. In particular, her discovery of a peculiar behavior of one of the main proteolytic zymogens: human trypsinogen 1, which was more readily activated into active trypsin than human trypsinogen 2 and trypsinogens of other species led her to propose that a premature intracellular activation of this zymogen may play a role in the pathogenesis of chronic pancreatitis. She demonstrated that a similar phenomenon may occur in cystic fibrosis (CF) and has applied this knowledge of pancreatic zymogens to follow the evolution of the pancreatic disease in CF. With this brief but keen biographical article Dr. Figarella shares her life experience as an innovative medical and biochemical investigator of human exocrine pancreatic function.

Original languageEnglish (US)
Pages (from-to)109-111
Number of pages3
JournalPancreatology
Volume10
Issue number2-3
DOIs
StatePublished - Jun 2010

Fingerprint

Enzyme Precursors
Trypsinogen
Cystic Fibrosis
Pancreatic Juice
Pancreatic Diseases
Life Change Events
Chronic Pancreatitis
Trypsin
Research Personnel
Proteins

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Hepatology

Cite this

Never conclude with a negative result, explore all possibilities before changing your hypothesis. / Fernandez-Zapico, Martin E.

In: Pancreatology, Vol. 10, No. 2-3, 06.2010, p. 109-111.

Research output: Contribution to journalArticle

@article{0049de32ac464f7e89913f58636619e3,
title = "Never conclude with a negative result, explore all possibilities before changing your hypothesis",
abstract = "Dr. Catherine Figarella is a world expert in the isolation and characterization of human exocrine pancreatic proteins (enzymatic and non-enzymatic ones). She was a pioneer in the identification and characterization of the numerous zymogens present in pancreatic juice. In particular, her discovery of a peculiar behavior of one of the main proteolytic zymogens: human trypsinogen 1, which was more readily activated into active trypsin than human trypsinogen 2 and trypsinogens of other species led her to propose that a premature intracellular activation of this zymogen may play a role in the pathogenesis of chronic pancreatitis. She demonstrated that a similar phenomenon may occur in cystic fibrosis (CF) and has applied this knowledge of pancreatic zymogens to follow the evolution of the pancreatic disease in CF. With this brief but keen biographical article Dr. Figarella shares her life experience as an innovative medical and biochemical investigator of human exocrine pancreatic function.",
author = "Fernandez-Zapico, {Martin E}",
year = "2010",
month = "6",
doi = "10.1159/000236898",
language = "English (US)",
volume = "10",
pages = "109--111",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "2-3",

}

TY - JOUR

T1 - Never conclude with a negative result, explore all possibilities before changing your hypothesis

AU - Fernandez-Zapico, Martin E

PY - 2010/6

Y1 - 2010/6

N2 - Dr. Catherine Figarella is a world expert in the isolation and characterization of human exocrine pancreatic proteins (enzymatic and non-enzymatic ones). She was a pioneer in the identification and characterization of the numerous zymogens present in pancreatic juice. In particular, her discovery of a peculiar behavior of one of the main proteolytic zymogens: human trypsinogen 1, which was more readily activated into active trypsin than human trypsinogen 2 and trypsinogens of other species led her to propose that a premature intracellular activation of this zymogen may play a role in the pathogenesis of chronic pancreatitis. She demonstrated that a similar phenomenon may occur in cystic fibrosis (CF) and has applied this knowledge of pancreatic zymogens to follow the evolution of the pancreatic disease in CF. With this brief but keen biographical article Dr. Figarella shares her life experience as an innovative medical and biochemical investigator of human exocrine pancreatic function.

AB - Dr. Catherine Figarella is a world expert in the isolation and characterization of human exocrine pancreatic proteins (enzymatic and non-enzymatic ones). She was a pioneer in the identification and characterization of the numerous zymogens present in pancreatic juice. In particular, her discovery of a peculiar behavior of one of the main proteolytic zymogens: human trypsinogen 1, which was more readily activated into active trypsin than human trypsinogen 2 and trypsinogens of other species led her to propose that a premature intracellular activation of this zymogen may play a role in the pathogenesis of chronic pancreatitis. She demonstrated that a similar phenomenon may occur in cystic fibrosis (CF) and has applied this knowledge of pancreatic zymogens to follow the evolution of the pancreatic disease in CF. With this brief but keen biographical article Dr. Figarella shares her life experience as an innovative medical and biochemical investigator of human exocrine pancreatic function.

UR - http://www.scopus.com/inward/record.url?scp=77951951139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951951139&partnerID=8YFLogxK

U2 - 10.1159/000236898

DO - 10.1159/000236898

M3 - Article

VL - 10

SP - 109

EP - 111

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 2-3

ER -